As the cost of developing new medicinal products has risen dramatically over the past decade and success rates remain almost unchanged, the need for more sensitive and specific screening tests in preclinical development has risen. At the same time there is a trend to include toxicology earlier in the discovery phase.
At this afternoon meeting we present the current progress and trends in toxicological research plus new technologies and tools at the hands of toxicologists in this fast evolving area.
Program
- Predictive Toxicology - Latest developments at Huntingdon. Stephen Ruckman, Huntingdon Life Science
- Toxicogenomics - Overview of the technology and applications. Nina Ostenfeldt, Lundbeck
- Genotoxicity assay; early experience with implementation of GreenScreen. Peter L. Madsen, Lundbeck
- QSAR and read across. Karl Heinz Cohr, DHI
- InnoMed PredTox - A joint Industry and European Commission collaboration to improve drug safety. Dorrit Baunsgård, Novo Nordisk
- Biologicals - challenges in preclinical development and regulatory process. Vibeke Breinholt, Genmab
- SIMKROP - whole body simulation; an innovation project. Flemming T. Hansen, DHI
- Optimization of information flow - faster decision making. Anne G. Eslau, Devoteam
Date and place
Thursday 11 September 2008, 12.00-16.00 hrs
Meeting will be held at
Søhuset
Scion-DTU Science Park
Venlighedsvej 10
DK-2970 Hørsholm
Registration fee
DKK 500 exclusive of VAT
Registration
Vibeke Salmon